WebAtorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer Latest version (submitted April 11, 2024) on ClinicalTrials.gov A study version is represented by a row in the table. Select two study versions to compare. One each from columns A and B. WebCisplatin-induced ototoxicity results in significant, permanent hearing loss in pediatric and adult cancer survivors. Elucidating the mechanisms underlying cisplatin-induced hearing loss as well as the development of therapies to reduce and/or reverse cisplatin ototoxicity have been impeded by suboptimal animal models.
Audiologic Management of Individuals Receiving Cochleotoxic …
WebMar 25, 2024 · Cisplatin is considered one of the most ototoxic pharmacologic agents, typically causing bilateral high frequency sensorineural hearing loss with progression to lower frequencies with continued exposure. WebJun 7, 2024 · The chemotherapy cisplatin — commonly used to treat cancers such as breast, ovarian, and lung cancers — and a class of strong antibiotics known as aminoglycosides can cause irreversible hearing loss in approximately 20 to 40 percent of those who take the drugs. darwin group logo
Cisplatin Uses, Side Effects & Warnings - Drugs.com
WebFeb 16, 2024 · Common side effects of cisplatin may include: hearing problems; kidney problems; numbness or tingling; nausea, vomiting; or. bone marrow suppression. This is … WebCisplatin is a platinum-based chemotherapeutic that has long since been effective against a variety of solid-cancers, substantially improving the five-year survival rates for cancer patients. Its use has also historically been limited by its adverse drug reactions, or cisplatin-induced toxicities (CITs). WebOct 11, 2024 · Cisplatin is clinically very effective in reducing the mass of solid or central nervous system tumors, yet the incidence of hearing loss is cumulatively dose … bitbw cloud anmeldung